Jul 22, 2026
Summary Systemic lupus erythematosus is a highly unpredictable autoimmune disease characterized by fluctuating flares affecting multiple organs, impacting ~5 million people globally and ~513,000 diagnosed cases in the US (2025), with numbers expected to rise through 2036. Diagnosis is complex and lengthy, of...
Read More...
Jul 22, 2026
Summary SLE is a chronic autoimmune disease affecting multiple organs, with ~936K diagnosed cases across the 7MM in 2025 and expected growth by 2036. BENLYSTA (belimumab, GSK) remains the cornerstone biologic, targeting BLyS to reduce autoreactive B cells; it expanded into lupus nephritis, pediatrics, and mu...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper